Anorexia: Central and Peripheral Mechanisms

Pharmacotherapy of Cachexia

Volumn , Issue , 2005, Pages 17-30

  Perboni, Simona ^a   Mantovani, Giovanni ^a   Inui, Akio ^b   Takimoto, Yoshiyuki ^c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54349121401     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (73)

1. Nelson, K.A., The cancer anorexia-cachexia syndrome, Semin. Oncol., 27, 64, 2000.
2. Rossi-Fanelli, F. and Laviano, A., Cancer anorexia: a model for the understanding and treatment of secondary anorexia, Int. J. Cardiol., 85, 67, 2002.
3. Dixit, V.D. et al., Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells, J. Clin. Invest., 114, 57, 2004.
4. Strader, A.D. and Woods, S.C., Gastrointestinal hormones and food intake, Gastroenterology, 128, 75, 2005.
5. Hillebrand, J.J.G., de Wied, D., and Adan, R.A.H., Neuropeptides, food intake and body weight regulation: a hypothalamic focus, Peptides, 23, 2283, 2002.
6. Morton, GJ. and Schwartz, M.W., The NPY/AgRPneuron and energy homeostasis, Int. J. Obes, 25, S56, 2001.
7. Lechan, R.M. and Tatro, J.B., Editorial: hypothalamic melanocortin signaling in cachexia, Endocrinology, 142, 3288, 2001.
8. Tisdale, M.J., Cancer anorexia and cachexia, Nutrition, 17, 442, 2001 (CACS).
9. Woods, S.C., Gastrointestinal satiety signals. I. An overview of gastrointestinal signals that influence food intake, Am. J. Physiol. Gastrointest. Liver Physiol., 286, G7, 2004.
10. Davis, M.P. et al., Appetite and cancer-associated anorexia: a review, J. Clin. Oncol., 22, 1510, 2004.
11. Hellstrom, P.M. and Naslung, E., Interactions between gastric emptying and satiety, with special reference to glucagons-like peptide-1, Physiol. Behav., 74, 735, 2001.
12. Richardson, R.A. and Davidson, H.I.M., Nutritional demands in acute and chronic illness, Proc. Nutr. Soc., 62, 777, 2003.
13. Berteretche, M.V. et al., Decreased taste sensitivity in cancer patients under chemotherapy, Support Care Cancer, 12, 571, 2004.
14. Laviano, A. et al., Neurochemical mechanisms for cancer anorexia, Nutrition, 18, 100, 2002.
15. Moldawer, L.L., Rogy, M.A., and Lowry, S.F., The role of cytokines in cancer anorexia, J. Paraenter Enteral. Nutr., 16, 43, 1992.
16. Barber, M.D., Ross, J.A., and Fearon, K.C., Cancer Cahexia, Surg. Oncol., 8, 133, 1999.
17. Dantzen, R., Cytokine induced sickness behavior: mechanisms and implications, Ann. N.Y.Acad. Sci., 933, 222, 2001.
18. Inui, A., Cancer anorexia-cachexia syndrome, CA. Cancer J. Clin., 52, 72, 2002.
19. Wigmore, S.J. et al., Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer, Br. J. Surg., 84, 196, 1997.
20. Inui, A., Cancer anorexia-cachexia syndrome: are neuropeptides the key?, Cancer Res., 59, 4493, 1999.
21. Inui, A., Feeding and body-weight regulation by hypothalamic neuropeptides-mediation of the actions of leptin, Trends Neurosci., 22, 62, 1999.
22. Noguchi, Y. et al., Are cytokines possible mediators of cancer cachexia?, Surg. Today, 26, 467, 1996.
23. Matthys, P. and Billiau, A., Cytokines and cachexia, Nutrition, 13, 763, 1997.
24. Wang, W., Danielsson, A., Svanberg, E., and Lundholm, K., Lack of effects by tricyclic antidepressant and serotonin inhibitors on anorexia in MCG 101 tumor-bearing mice with eicosanoid-related cachexia, Nutrition, 19, 47, 2003.
25. Laviano, A. et al., Cracking the riddle of cancer anorexia, Nutrition, 12, 706, 1996.
26. Plata-Salaman, C.R., Cytokine-induced anorexia: Behavioral, cellular, and molecular mechanisms, Ann. N.Y. Acad. Sci., 856, 160, 1988.
27. Konsman, J.P. and Dantzer, R., How the immune and nervous systems interact during disease-associated anorexia?, Nutrition, 17, 664, 2001.
28. Langhans, W. and Hrupka, B., Interleukins and tumor necrosis factor as inhibitors of food intake, Neuropeptides, 33, 415, 1999.
29. Turrin, N.P. et al., Interleukin-1beta system in anorectic catabolic tumor-bearing rats, Curr. Opin. Clin. Metab. Care, 7, 419, 2004.
30. Martignoni, M., Kunze, P., and Friess, H., Cancer cachexia, Mol. Cancer, 2, 36, 2003.
31. McCarthy, D.O., Inhibitors of prostaglandin synthesis do not improve food intake or body weight of tumor-bearing rats, Res. Nurs. Health, 22, 380, 1999.
32. Tisdale, M.J., Cancer cachexia, Langenbercks Arch. Surg., 389, 299, 2004.
33. Mantovani, G. et al., Cytokine involvement in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate, Semin. Oncol., 25, 45, 1998.
34. Jatoi, A. et al., Does megastrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group Investigation, Support Care Cancer, 10, 71, 2002.
35. Maltoni, M. et al., Serum levels of tumor necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients, Support Care Cancer, 5, 130, 1997.
36. Turrin, N.P. et al., Interleukin-1beta system in anorectic catabolic tumor-bearing rats, Curr. Opin. Clin. Metab. Care, 7, 419, 2004.
37. Machado, A.P., Costa Rosa, L.F.P.B., and Seelaender, M.C.L., Adipose tissue in Walker 256 tumour-induced cachexia: possible association between decreased leptin concentration and mononuclear cell infiltration, Cell Tissue Res., 318, 53, 2004.
38. Lugarini, F. et al., Acute and chronic administration of immunomodulators induces anorexia in zucher rats, Physiol. Behav., 84, 165, 2005.
39. Somasundar, P. et al., Leptin is a growth factor in cancer, J. Surg. Res., 116, 337, 2004.
40. Aleman, M.R. et al., Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition?, Cytokine, 19, 21, 2002.
41. Simons, J.P. et al., Plasma concentration of total leptin and human lung-cancer-associated cachexia, Clin. Sci. (Lond.), 93, 273, 1997.
42. Brown, D.R., Berkowitz, D.E., and Breslow, M.J., Weight loss is not associated with hyperleptinemia in humans with pancreatic cancer, J. Clin. Endocrinol. Metab., 86, 162, 2001.
43. Wallace, A.M., Sattar, N., and McMillan, D.C., Effect of weight loss and the inflammatory response on leptin concentrations in gastrointestinal cancer patients, Clin. Cancer Res., 4, 2977, 1998.
44. Mantovani, G. et al., Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites, J. Mol. Med., 78, 554, 2000.
45. Bing, C. et al., Cachexia in MAC16 adenocarcinoma: suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y, J. Neurochem., 79, 1004, 2001.
46. Inui, A., Ghrelin: an orexigenic and somatotrophic signal from the stomach, Nat. Rev. Neurosci., 2, 551, 2001.
47. Tschop, M. et al., GH-Releasing Peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic Agouti-related protein, Endocrinology, 143, 558, 2004.
48. Plata-Salaman, C.R., Central nervous system mechanisms contributing to the cachexia-anorexia syndrome, Nutrition, 16, 1009, 2000.
49. Neary, N.M. et al., Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial, J. Clin. Endocrinol. Metab., 89, 2832, 2004.
50. Garcia, J.M. et al., Active ghrelin levels and active/total ghrelin ratio in cancer-induced cachexia, J. Clin. Endocrinol. Metab. 90, 2920, 2005.
51. Shimizu, Y. et al., Increased plasma ghrelin level in lung cancer cachexia, Clin. Cancer Res., 9, 774, 2003.
52. Hanada, T. et al., Upregulation of ghrelin expression in cachectic nude mice bearing human melanoma cells, Metabolism, 53, 84, 2004.
53. Zigman, J.M. and Elmquist, J.K., Minireview: from anorexia to obesity - The yin and yang of body weight control, Endocrinology, 144, 3749, 2003.
54. Asakawa, A. et al., Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin, Gastroenterology, 120, 337, 2001.
55. Marks, D.L., Ling, N., and Cone, R.D., Role of the central melanocortin system in cachexia, Cancer Res., 61, 1432, 2001.
56. Wisse, B.E. et al., Reversal of cancer anorexia by blockade of central melanocortin receptors in rats, Endocrinology, 142, 3292, 2001.
57. Inui, A. et al., Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ, FASEB J., 18, 439, 2004.
58. Foster, A.C. et al., Body weight regulation by selective MC4 receptor agonists and antagonists, Ann. N.Y. Acad. Sci., 994, 103, 2003.
59. Wisse, B.E., Schwartz, M.W., and Cummings, D.E., Melanocortin signaling and anorexia in chronic disease states, Ann. N.Y. Acad. Sci., 994, 275, 2003.
60. Ramos, E.J. et al., Cancer anorexia-cachexia syndrome: cytokines and neuropeptides, Curr. Opin. Clin. Nutr. Care, 7, 427, 2004.
61. Makarenko, I.G et al., Hypothalamic 5-HT1B-receptor changes in anorectic bearing rats, Neurosci. Lett., 376, 71, 2005.
62. Shintani, F. et al., Interleukin-1beta augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus, J. Neurosci., 7, 3574, 1993.
63. Laviano, A. et al., Effects of intra-VMN mianserin and IL-1ra on meal number in anorectic tumour-bearing rats, J. Invest. Med., 48, 40, 2000.
64. Heisler, L.K. et al., Activation of central melanocortin pathways by fenfluramine, Science, 297, 609, 2002.
65. Meguid, M.M., et al., Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus, Peptides, 25, 261, 2004.
66. Makarenko, I.G. et al., Decreased NPY innervation of the hypothalamic nuclei in rats with cancer anorexia, Brain Res., 961, 100, 2003.
67. Sonti, G., Llyin, S.E., and Plata-Salaman, C.R., Neuropeptide Y blocks and reveres interleukin-1^-induced anorexia in rats, Peptides, 17, 517, 1996.
68. Gayle, D., Llyin, S.E., and Plata-Salaman, C.R., Central nervous system IL-1ß system and neuropeptide Y mRNA during IL-1ß - induced anorexia in rats, Brain Res. Bull., 44, 311, 1997.
69. Sonti, G., Llyin, S.E., and Plata-Salaman, C.R., Anorexia induced by cytokine interactions at pathophysiological concentrations, Am. J. Physiol., 270, 1349, 1996.
70. Lopez, A.P. et al., Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome, J. Pain Symptom Manage., 27, 360, 2004.
71. McCarthy, H.D. et al., Megestrol acetate stimulates food intake and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations, Eur. J. Pharmacol., 256, 99, 1994.
72. Ramos, E.J.B. et al., Neuropeptide Y, a-melanocyte-stimulating-hormone, and monoamines in food intake regulation, Nutrition, 21, 269, 2005.
73. Strasser, F., Eating-related disorders in patients with advanced cancer, Support Care Cancer, 11, 11, 2003